I disagree with both points. I would say he is indeed a Matt Levine of his field. Perhaps I'm misunderstanding the author's argument though. 1. His posts are i

I disagree with both points. I would say he is indeed a Matt Levine of his field. Perhaps I'm misunderstanding the author's argument though. 1. His posts are inside-baseball - this is true for some posts, but many are written to be approachable to all audiences, especially during the coronavirus. This is similar for Matt Levine's posts, but as a finance nerd, not a drug discovery one, the author does not see this. 2. [His posts] do not repeat themes - he has many examples of repeated themes, including the whole science-over-money aspect of the Aducanumab saga, various times he has touched on "AI" drug discovery, and the whole Things I Won't Work With series.